The impact of pectin supplementation on systemic inflammation pathways, gut microbiome, and metabolic health in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A study protocol for a randomised controlled trial
Noor Kifah Al-Tameemi, Jane I Grove, Caroline L Hoad, Jessica Wong Sun Wai, Adina Olaru, Saikat Mandal, Katie E Rollins, Christopher R Bradley · 2026
Read The impact of pectin supplementation on systemic inflammation pathways, gut microbiome, and metabolic health in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A study protocol for a randomised controlled trial by Noor Kifah Al-Tameemi, Jane I Grove, Caroline L Hoad, Jessica Wong Sun Wai, Adina Olaru, Saikat Mandal, Katie E Rollins, Christopher R Bradley (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0352397.txt.
Description
Al-Tameemi and colleagues set out a trial plan in 2026 on a fruit fiber supplement for fatty liver disease. The disease, tied to body metabolism, is now the leading cause of long-term liver trouble worldwide. Thirty adults in Nottingham will take either the fiber, called pectin, or a dummy supplement for six weeks, with neither side knowing which.
Blood, stool, and body measures will be taken before and after to track inflammation, gut microbes, and metabolic health. Gut changes are a prime suspect in how fiber might calm the liver. A small careful trial like this tests both benefit and practicality before a larger study is funded.
Catalog record
| CREATOR | Noor Kifah Al-Tameemi, Jane I Grove, Caroline L Hoad, Jessica Wong Sun Wai, Adina Olaru, Saikat Mandal, Katie E Rollins, Christopher R Bradley |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49537 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |